Dear Colleagues,

Professor Pierre Vogel was born in Cully (Switzerland). He did his Ph. D under the supervision of Prof. H. Prinzbach, at the Institute of Organic Chemistry, in the University of Lausanne. He carried out post-doctoral research at Yale University (New Haven, Connecticut, USA), collaborating with Profs. M. Saunders, J.A. Berson, K.A. Wiberg and P.v.R. Schleyer (Princeton University). He then moved to Mexico City, where he worked as a Research chemist at Syntex S.A. with Prof. P. Crabbé.

In 1973, he returned to the University of Lausanne, where he became Professor of organic chemistry in 1977. In 1976, he received the Alfred Werner Medal of the Swiss Chemical Society. He was part-time doctoral schoolteacher at the Universities of Rouen and Caen from 1991 to 1993 and part-time professor at the Ecole Polytechnique in Palaiseau (France) from 1993 to 2000. He was Vice-Chairman of the Institute of Organic Chemistry at the University of Lausanne from 1991 until 2001. He was Pacific Coast (USA) Lecturer in 1992, and invited professor at the Universities of Montpellier, Paris-Sud, Ecole Supérieure de physique et de chemie industrielles de la ville de Paris (ESPCI) and Complutense (Madrid). He was awarded with the Novartis Lecturership in 2003 and was Boeringer Ingelheim Distinguished Lecturer in 2005. From 2000 to 2001, he was a reviewer of the Institut Universitaire de France, and as of 2001, Professor of organic chemistry at the Ecole Polytechnique Fédérale de Lausanne (EPFL). He also served as the Director of the doctoral program in chemistry and chemical engineering of the EPFL (2002–2010). Since 2011, he has been an Honorary Professor of the EPFL, responsible of the medicinal chemistry laboratory of the Ludwig Institute for Cancer Research, in collaboration with the EPFL. He also participates in the European FP7 health program on pancreatic cancer.

Complementing his research, Prof. Pierre Vogel has contributed more than five hundred articles in refereed journals, eleven patents, and three books.

The articles in this Special Issue represent contributions from many friends and former co-workers of Prof. Vogel who, in this way, want to show their appreciation for and friendship to Pierre.

Prof. Dr. Jose A. Sordo
Prof. Dr. Chandra M. R. Volla
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Catalysts is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• Asymmetric total synthesis of natural products and analogues of biological interest: e.g: nonactin, polyketides, polypropionates, indolizidines, castanospermine, ryfamycin, spongistatins, apoptolidin
• Combinatorial synthesis
• Multicomponent synthesis
• Furans as starting materials in fine chemistry, Biomass derived synthetic intermediates: e.g.: levoglucosenone, isolevoglucosenone
• Glycochemistry, carbohydrates, glycomimetics, total synthesis of sugars
• Anticancer agents, anthracyclines, iminoalditols, iminoaldoses, C-nucleosides, deoxypolyoxin-C, C-disaccharides, imino-C-disaccharides, carbasugars, conduritols, aminoconduritols, NAMPT inhibitors, ID
• Anti-cancer vaccine candidate: C-disaccharide TF epitope analogues
• Physical organic chemistry: e.g.: reaction mechanisms, isotopic effects, carbocations as intermediates, electron-releasing carbonyl group, barrelene effect, norbornene effects, non-planarity of pi-sys
• Pericyclic reactions: e.g.: hetero-Diels-Alder, [4+3]-cycloaddition, cheletropic addition, dyotropic transfer of dihydrogen, Wagner-Meerwein rearrangements, sigmatropic rearrangements, ene-reactions
• Synthesis of compounds of theoretical interest: e.g.: [l.m.n]hericenes
• New organic chemistry of sulfur dioxide: e.g.: two-directional asymmetric synthesis of long chain polypropionates, new silylation reagents, direct amidification of carboxylic acids. Homogenous catalys
• Transition organometallic chemistry